166 related articles for article (PubMed ID: 24747176)
1. Transcriptional regulation of the human thromboxane A2 receptor gene by Wilms' tumor (WT)1 and hypermethylated in cancer (HIC) 1 in prostate and breast cancers.
Keating GL; Reid HM; Eivers SB; Mulvaney EP; Kinsella BT
Biochim Biophys Acta; 2014 Jun; 1839(6):476-92. PubMed ID: 24747176
[TBL] [Abstract][Full Text] [Related]
2. Regulated expression of the TPβ isoform of the human T prostanoid receptor by the tumour suppressors FOXP1 and NKX3.1: Implications for the role of thromboxane in prostate cancer.
O'Sullivan AG; Eivers SB; Mulvaney EP; Kinsella BT
Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3153-3169. PubMed ID: 28890397
[TBL] [Abstract][Full Text] [Related]
3. The Wilms' tumour suppressor protein WT1 acts as a key transcriptional repressor of the human thromboxane A2 receptor gene in megakaryocytes.
Gannon AM; Kinsella BT
J Cell Mol Med; 2009; 13(11-12):4571-86. PubMed ID: 19067769
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of the TPα and TPβ isoforms of the human T Prostanoid receptor during chronic inflammation of the prostate: Role for FOXP1 in the transcriptional regulation of TPβ during monocyte-macrophage differentiation.
Mulvaney EP; O'Sullivan ÁG; Eivers SB; Reid HM; Kinsella BT
Exp Mol Pathol; 2019 Oct; 110():104277. PubMed ID: 31271729
[TBL] [Abstract][Full Text] [Related]
5. Regulated expression of the alpha isoform of the human thromboxane A2 receptor during megakaryocyte differentiation: a coordinated role for WT1, Egr1, and Sp1.
Gannon AM; Turner EC; Reid HM; Kinsella BT
J Mol Biol; 2009 Nov; 394(1):29-45. PubMed ID: 19747485
[TBL] [Abstract][Full Text] [Related]
6. Expression of the TPα and TPβ isoforms of the thromboxane prostanoid receptor (TP) in prostate cancer: clinical significance and diagnostic potential.
Mulvaney EP; Shilling C; Eivers SB; Perry AS; Bjartell A; Kay EW; Watson RW; Kinsella BT
Oncotarget; 2016 Nov; 7(45):73171-73187. PubMed ID: 27689401
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase C-related kinase 1 and 2 play an essential role in thromboxane-mediated neoplastic responses in prostate cancer.
O'Sullivan AG; Mulvaney EP; Hyland PB; Kinsella BT
Oncotarget; 2015 Sep; 6(28):26437-56. PubMed ID: 26296974
[TBL] [Abstract][Full Text] [Related]
8. Synthetic peroxisome proliferator-activated receptor gamma agonists rosiglitazone and troglitazone suppress transcription by promoter 3 of the human thromboxane A2 receptor gene in human erythroleukemia cells.
Coyle AT; Kinsella BT
Biochem Pharmacol; 2006 Apr; 71(9):1308-23. PubMed ID: 16499875
[TBL] [Abstract][Full Text] [Related]
9. 15-deoxy Delta12,14-prostaglandin J2 suppresses transcription by promoter 3 of the human thromboxane A2 receptor gene through peroxisome proliferator-activated receptor gamma in human erythroleukemia cells.
Coyle AT; O'Keeffe MB; Kinsella BT
FEBS J; 2005 Sep; 272(18):4754-73. PubMed ID: 16156795
[TBL] [Abstract][Full Text] [Related]
10. Regulation of protein kinase C-related kinase (PRK) signalling by the TPα and TPβ isoforms of the human thromboxane A
O'Sullivan AG; Mulvaney EP; Kinsella BT
Biochim Biophys Acta Mol Basis Dis; 2017 Apr; 1863(4):838-856. PubMed ID: 28108419
[TBL] [Abstract][Full Text] [Related]
11. Regulation of the human thromboxane A2 receptor gene by Sp1, Egr1, NF-E2, GATA-1, and Ets-1 in megakaryocytes.
Gannon AM; Kinsella BT
J Lipid Res; 2008 Dec; 49(12):2590-604. PubMed ID: 18698092
[TBL] [Abstract][Full Text] [Related]
12. Identification of an interaction between the TPalpha and TPbeta isoforms of the human thromboxane A2 receptor with protein kinase C-related kinase (PRK) 1: implications for prostate cancer.
Turner EC; Kavanagh DJ; Mulvaney EP; McLean C; Wikström K; Reid HM; Kinsella BT
J Biol Chem; 2011 Apr; 286(17):15440-57. PubMed ID: 21357687
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
Zaia A; Fraizer GC; Piantanelli L; Saunders GF
Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
[TBL] [Abstract][Full Text] [Related]
14. Characterization of promoter 3 of the human thromboxane A receptor gene. A functional AP-1 and octamer motif are required for basal promoter activity.
Coyle AT; Kinsella BT
FEBS J; 2005 Feb; 272(4):1036-53. PubMed ID: 15691336
[TBL] [Abstract][Full Text] [Related]
15. Correlation of Wilms' tumor 1 isoforms with HER2 and ER-α and its oncogenic role in breast cancer.
Nasomyon T; Samphao S; Sangkhathat S; Mahattanobon S; Graidist P
Anticancer Res; 2014 Mar; 34(3):1333-42. PubMed ID: 24596380
[TBL] [Abstract][Full Text] [Related]
16. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.
Han Y; San-Marina S; Yang L; Khoury H; Minden MD
Breast Cancer Res; 2007; 9(4):R43. PubMed ID: 17634147
[TBL] [Abstract][Full Text] [Related]
17. The Wilms' tumor gene (WT1) regulates E-cadherin expression and migration of prostate cancer cells.
Brett A; Pandey S; Fraizer G
Mol Cancer; 2013 Jan; 12():3. PubMed ID: 23298185
[TBL] [Abstract][Full Text] [Related]
18. Wilms' tumor gene 1 protein represses the expression of the tumor suppressor interferon regulatory factor 8 in human hematopoietic progenitors and in leukemic cells.
Vidovic K; Svensson E; Nilsson B; Thuresson B; Olofsson T; Lennartsson A; Gullberg U
Leukemia; 2010 May; 24(5):992-1000. PubMed ID: 20237505
[TBL] [Abstract][Full Text] [Related]
19. Endoplasmic reticulum stress induces PRNP prion protein gene expression in breast cancer.
Déry MA; Jodoin J; Ursini-Siegel J; Aleynikova O; Ferrario C; Hassan S; Basik M; LeBlanc AC
Breast Cancer Res; 2013 Mar; 15(2):R22. PubMed ID: 23497519
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
